Support our Foundation of Myology project
2414 news items
Chinese study highlights importance of cognitive impairment in myasthenia gravis
On 24/04/2024
The existence of cognitive disorders in autoimmune myasthenia is still debated. Chinese researchers have investigated this question using a battery of tests: 41 patients with…
MYOLOGY 2024: focus on the institute speakers
On 22/04/2024
The 8th International Congress of Myology will be held in Paris from 22 to 25 April 2024. Here are the eight themes that experts from…
Initial results of the “Adult polyglucosan disease” register
On 19/04/2024
The Columbia University team publishes data collected since 2014 in the Columbia University APBD Registry (CAP ) and filled in by patients with adult polyglucosan…
Vamorolone confirms its efficacy over one year in DMD without limiting growth
On 17/04/2024
In 2022 , the first results of a 6-month double-blind trial of vamorolone (Agamree®) versus placebo or prednisone were published. This synthetic steroid has been…
DMD: Commercial go-ahead for givinostat (Duvyzat™) in the USA
On 15/04/2024
Givinostat, a drug developed by Italfarmaco for Duchenne and Becker muscular dystrophies, is a histone deacetylase (HDAC) inhibitor. On 21 March 2024, it was granted…
A probable founder effect in a hereditary neuropathy with cyclic vomiting
On 11/04/2024
French clinicians and biologists report the observations of three families of North African origin who were diagnosed with deficiency of SMVT, a sodium-dependent multi-vitamin transporter:…
GDF5, a “rejuvenating” treatment for age-related neuromuscular deficiency in mice
On 09/04/2024
A study conducted by the MOOVE* research team headed by France Pietri-Rouxel, in collaboration with several teams from the Institute and Sorbonne University, has just…
Researchers from the institute at the IDMC14 conference to present their work
On 09/04/2024
Researchers and clinicians from the Institute of Myology will be present at the 14th International Myotonic Dystrophy Consortium Meeting (IDMC14) which takes place from 9…
Clinicians and researchers from the Institute at the Journées de neurologie de langue française
On 08/04/2024
The Journées de neurologie de langue française will be held in Paris from 9 to 12 April 2024. The main aim of these days is…
Atamyo Therapeutics obtains authorisation to launch a gene therapy clinical trial in limb-girdle muscular dystrophy linked to SGCG
On 08/04/2024
Following several proofs of concept, Atamyo Therapeutics, a spin-off from Geenethon, has obtained authorisation to start a new gene therapy trial in patients suffering from…
Prenatal diagnosis is sometimes complicated by the results of high-throughput sequencing.
On 08/04/2024
A team from Dijon reports on a complex situation involving a consanguineous couple whose foetus carried adevelopmental anomaly known as cystic hygroma: a whole exome…
An ultra-rare myopathy, but important to recognise because it can be treated
On 05/04/2024
Clinicians in London report the observation of a 27-year-old patient diagnosed with arginine-glycine amidino-transferase (AGAT) deficiency myopathy: the clinical picture combined myopathy and cognitive difficulties…
Failure of the ryanodine receptor causes myocardial senescence and fibrosis in DMD
On 04/04/2024
Researchers in the south of France have studied the determinants of the degeneration and fibrosis observed in cardiomyopathy linked to Duchenne muscular dystrophy (DMD) in…
A new method for assessing treatment efficacy in Pompe disease
On 03/04/2024
To assess the efficacy of enzyme replacement therapy, Dutch researchers and clinicians are proposing a new methodology: the clinical and paraclinical data of 102 patients…
Neonatal screening for Pompe disease: a compilation of all existing data
On 02/04/2024
Two American researchers have compiled data from the literature on newborn screening for Pompe disease worldwide: 29 programmes are in place and operational in eight…
Experts from the institute will present their research findings at Myology 2024
On 02/04/2024
Researchers and clinicians from the Institute of Myology will be presenting their findings at the next international myology congress, Myology 2024, organized by AFM-Téléthon from…
Natural history of X-linked myopathy with excessive autophagy
On 02/04/2024
X-linked myopathy with excessive autophagy (XMEA) is a little-known disease linked to the VMA21 gene. It leads to autophagy failure with progressive vacuolation and atrophy…
TOPAZ trial of apitegromab in SMA
On 29/03/2024
The TOPAZ trial tested the safety, tolerability and efficacy of the anti-myostatin apitegromab in SMA over one year in the United States and Europe (but…
Telethon 2023: 92,905,533 euros, thanks to you, an exceptional fundraising campaign. Thank you for your support!
On 28/03/2024
92,905,533 was the final amount raised by the Telethon held on 8 and 9 December 2023. This exceptional result bears witness to the unfailing mobilisation…
Charcot-Marie-Tooth disease: one in two orthotic devices prescribed is no longer used over time
On 28/03/2024
An online survey of 266 Italian patients suffering from Charcot–Marie–Tooth (CMT) disease shows the low use of lower–limb orthoses: 70% of participants had received a…